Founded in 1991, Vircell was established as a biotechnology company focused on creating and manufacturing reagents for the diagnosis of human infectious diseases utilizing a variety of techniques, including ready-to-use CLIA monotests and the most advanced molecular biology developments. As a successful global business, Vircell distributes its products to more than 90 countries across the five continents.
